Management of smoking cessation in patients with psychiatric disorders

Current Medical Research and Opinion

Volumn 25, Issue 2, 2009, Pages 511-518

  Fagerström, Karl ^a   Aubin, Henri Jean ^b,c,d,e  

^a Fagerstrom Consulting   (Sweden)

^b Hôpitaux Universitaires Henri Mondor   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e Universite Paris Sud   (France)

Author keywords

Depression; Nicotine withdrawal; Psychiatric disorders; Schizophrenia; Smoking cessation

Indexed keywords

AMFEBUTAMONE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; NICOTINE GUM; NICOTINE PATCH; OLANZAPINE; VARENICLINE;

CLINICAL TRIAL; DEPRESSION; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MEDLINE; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH SERVICE; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SELF MEDICATION; SMOKING; SMOKING CESSATION; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; WITHDRAWAL SYNDROME;

HUMANS; MENTAL DISORDERS; SMOKING; SMOKING CESSATION;

EID: 64249117578     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802707568     Document Type: Review

References (61)

1. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005;14:106-123 (Pubitemid 40577885)
2. McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 2002; 181:321-325 (Pubitemid 35178564)
3. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004;29:1067-1083 (Pubitemid 38962332)
4. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004;61:1107-1115 (Pubitemid 39463411)
5. Johnson JG, Cohen P, Pine DS, et al. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 2000;284:2348-2351 (Pubitemid 30828679)
6. Patton GC, Carlin JB, Coffey C, et al. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health 1998;88:1518-1522 (Pubitemid 28455761)
7. Goodman E, Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics 2000;106:748-755 (Pubitemid 30769203)
8. George TP, Ziedonis DM, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000;157:1835-1842 (Pubitemid 30813141)
9. Niaura R, Britt DM, Shadel WG, et al. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 2001;15:13-17 (Pubitemid 32194935)
10. Baker A, Richmond R, Haile M, et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Res 2007;150:141-152 (Pubitemid 46386295)
11. Carosella AM, Ossip-Klein DJ, Owens CA. Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav 1999; 24:331-344 (Pubitemid 29252584)
12. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:1157-1161
13. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000;177:212-217 (Pubitemid 30707552)
14. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-1121 (Pubitemid 41773510)
15. Montoya ID, Herbeck DM, Svikis DS, et al. Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. Am J Addict 2005;14:441-454 (Pubitemid 43372027)
16. Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control 2004;13:206 (Pubitemid 39452023)
17. Dursun SM, Kutcher S. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Med Hypotheses 1999; 52:101-109 (Pubitemid 29178628)
18. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996;36:597-613 (Pubitemid 26168710)
19. Bock BC, Goldstein MG, Marcus BH. Depression following smoking cessation in women. J Subst Abuse 1996;8:137-144 (Pubitemid 26233207)
20. Niaura R, Britt DM, Borrelli B, et al. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res 1999;1:251-257
21. Adler LE, Olincy A, Waldo M, et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 1998;24:189-202 (Pubitemid 28404980)
22. Kumari V, Soni W, Sharma T. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 2001;16:321-326 (Pubitemid 32655166)
23. Olincy A, Ross RG, Young DA, et al. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology 1998;18:175-185 (Pubitemid 28062581)
24. Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998;155:1490-1501 (Pubitemid 28512015)
25. Malpass D, Higgs S. Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls. Psychopharmacology (Berl) 2007; 190:363-372 (Pubitemid 46155645)
26. Kinnunen T, Doherty K, Militello FS, et al. Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. J Consult Clin Psychol 1996; 64:791-798 (Pubitemid 26274542)
27. Salin-Pascual RJ, Rosas M, Jiménez-Genchi A, et al. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996;57:387-389 (Pubitemid 26321988)
28. van Amsterdam J, Talhout R, Vleeming W, et al. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction. Life Sci 2006;79:1969-1973 (Pubitemid 44528577)
29. Lyons M, Hitsman B, Xian H, et al. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob Res 2008;10:97-108
30. Kendler KS, Neale MC, MacLean CJ, et al. Smoking and major depression. A causal analysis. Arch Gen Psychiatry 1993;50:36-43
31. Fiore M, Jaén C, Baker T. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD. U.S: Department of Health and Human Services. Public Health Service, 2008
32. Evins AE, Deckersbach T, Cather C, et al. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry 2005;66:1184-1190 (Pubitemid 41442287)
33. Brown RA, Niaura R, Lloyd-Richardson EE, et al. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res 2007;9:721-730 (Pubitemid 47009227)
34. Stapleton JA, Watson L, Spirling LI, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 2007; 103:146-154 (Pubitemid 350233424)
35. Freedman R. Exacerbation of schizophrenia by varenicline. Am J Psychiatry 2007;164:1269 (Pubitemid 47292423)
36. Kohen I, Kremen N. Varenicline-induced manic episode in a patient with bipolar disorder. Am J Psychiatry 2007; 164:1269-1270 (Pubitemid 47292424)
37. Evins AE, Goff DC. Varenicline treatment for smokers with schizophrenia: a case series. J Clin Psychiatry 2008;69:1016 (Pubitemid 351944959)
38. El-Guebaly N, Cathcart J, Currie S, et al. Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 2002;53:1166-1170 (Pubitemid 34976630)
39. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs 2001;15:469-494 (Pubitemid 32601905)
40. Ereshefsky L, Jann MW, Saklad SR, et al. Effects of smoking on fluphenazine clearance in psychiatric inpatients. Biol Psychiatry 1985;20:329-332 (Pubitemid 16036399)
41. Zullino DF, Delessert D, Eap CB, et al. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol 2002;17:141-143 (Pubitemid 34442196)
42. Broocks A, Bandelow B, Koch K, et al. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder. Neuropsychopharmacology 2002;27:270-278 (Pubitemid 34686977)
43. Rohsenow DJ, Tidey JW, Miranda R, et al. Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp Clin Psychopharmacol 2008;16:215-222 (Pubitemid 351822565)
44. McEvoy JP, Freudenreich O, Levin ED, et al. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl) 1995;119:124-126
45. McEvoy J, Freudenreich O, McGee M, et al. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 1995;37:550-552
46. Hughes JR, Gust SW, Skoog K, et al. Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 1991;48:52-59
47. Dalack GW, Meador-Woodruff JH. Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature. Schizophr Res 1996;22:133-141 (Pubitemid 26394560)
48. Prochaska JJ, Hall SM, Tsoh JY, et al. Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public Health 2008;98:446-448 (Pubitemid 351354511)
49. McChargue DE, Gulliver SB, Hitsman B. Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction 2002;97:785-793
50. Binkin N, Perra A, Aprile V, et al. Effects of a generalised ban on smoking in bars and restaurants, Italy. Int J Tuberc Lung Dis 2007;11:522-527 (Pubitemid 46732638)
51. Hu SC, Huang SY, Li D, et al. Workplace smoking policies in Taiwan and their association with employees' smoking behaviours. Eur J Public Health 2005;15:270-275 (Pubitemid 41399555)
52. Pierce J, Leon M, on behalf of the IARC Handbook Volume13 Working Group and IARC Secretariat. Special Report: Policy. Effectiveness of smoke-free policies. Lancet Oncolocy 2008;9:614-615
53. Campion J, Checinski K, Nurse J, et al. Smoking by people with mental illness and benefits of smoke-free mental health services. Adv Psychiatr Treat 2008;14:217-228
54. McNally L, Oyefeso A, Annan J, et al. A survey of staff attitudes to smoking-related policy and intervention in psychiatric and general health care settings. J Public Health (Oxf) 2006;28:192-196 (Pubitemid 44408919)
55. Campion J, Lawn S, Brownlie A, et al. Implementing smoke-free policies in mental health inpatient units: learning from unsuccessful experience. Australas Psychiatry 2008;16:92-97
56. Jiménez-Ruiz C, Solano S, Viteri SA, et al. Harm reduction - a treatment approach for resistant smokers with tobacco-related symptoms. Respiration 2002;69:452-455
57. Haug NA, Hall SM, Prochaska JJ, et al. Acceptance of nicotine dependence treatment among currently depressed smokers. Nicotine Tob Res 2005;7:217-224 (Pubitemid 40852148)
58. Pohl JM, Martinelli A, Antonakos C. Predictors of participation in a smoking cessation intervention group among low-income women. Addict Behav 1998;23:699-704 (Pubitemid 28410849)
59. Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health 2006;96:1808-1814 (Pubitemid 44497738)
60. Miller W. Motivational Interviewing: Preparing People for Change. 2nd edn. New York, NY: Guilford Press, 2002
61. Williams JM, Foulds J. Successful tobacco dependence treatment in schizophrenia. Am J Psychiatry 2007;164:222-227 (Pubitemid 46318558)